PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹570 Cr | ₹547 Cr | ₹657 Cr | ₹853 Cr | ₹774 Cr |
What is the latest Total Current Liabilities ratio of PFIZER ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹570 Cr |
| Mar2024 | ₹547 Cr |
| Mar2023 | ₹657 Cr |
| Mar2022 | ₹853 Cr |
| Mar2021 | ₹774 Cr |
How is Total Current Liabilities of PFIZER Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹570 Cr | 4.20 | |
| Mar2024 | ₹547 Cr | -16.85 | |
| Mar2023 | ₹657 Cr | -22.93 | |
| Mar2022 | ₹853 Cr | 10.14 | |
| Mar2021 | ₹774 Cr | - | |
Compare Total Current Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹22,862.8 Cr | 0.6% | -2.1% | -6.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,343.0 Cr | -0.7% | 7.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,774.0 Cr | -0.1% | -4.8% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,665.0 Cr | 2.2% | 6.3% | 11.4% | Stock Analytics | |
| CIPLA | ₹122,878.0 Cr | -0.6% | 1.2% | NA | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,581.0 Cr | 1.5% | 6.4% | 4.8% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 0.6% |
-2.1% |
-6.7% |
| SENSEX | -0.5% |
1.5% |
6.9% |
You may also like the below Video Courses